Innoviva (INVA) Change in Accured Expenses (2010 - 2026)

Innoviva (INVA) posted Change in Accured Expenses of -$1.4 million for Q1 2026, up 56.53% on a QoQ basis from -$3.2 million in Q3 2025, and up 46.43% year-over-year from -$947228.4 in Q1 2025.

Innoviva (INVA) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Innoviva's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 46.43% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (up 78.86% YoY) and the FY2025 annual result came in at -$1.8 million, changed N/A from the prior year.
  • Change in Accured Expenses was -$1.4 million for Q1 2026 at Innoviva, up from -$3.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $4.5 million in Q2 2025 and bottomed at -$6.4 million in Q2 2024.
  • A 5-year average of -$1.6 million and a median of -$2.6 million in 2025 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2024 — Change in Accured Expenses soared 178.05% — and 2025, when it slumped 687.07%.
  • Innoviva's Change in Accured Expenses stood at -$1.9 million in 2022, then plunged by 83.07% to -$3.5 million in 2023, then retreated by 12.79% to -$4.0 million in 2024, then advanced by 19.76% to -$3.2 million in 2025, then surged by 56.53% to -$1.4 million in 2026.
  • Business Quant data shows INVA's Change in Accured Expenses at -$1.4 million in Q1 2026, -$3.2 million in Q3 2025, and $4.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.13 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -16.82 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -16.74 Mn
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn -1.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.39 Mn
Mar 31, 2026 -1.39 Mn
Sep 30, 2025 -3.19 Mn
Sep 30, 2025 -3.19 Mn
Jun 30, 2025 4.52 Mn
Jun 30, 2025 4.52 Mn
Mar 31, 2025 -2.59 Mn
Mar 31, 2025 -2.59 Mn
Sep 30, 2024 -3.98 Mn
Sep 30, 2024 -3.98 Mn
Jun 30, 2024 -6.39 Mn
Jun 30, 2024 -6.39 Mn
Mar 31, 2024 441,000.00
Mar 31, 2024 441,000.00
Sep 30, 2023 -3.53 Mn
Sep 30, 2023 -3.53 Mn
Jun 30, 2023 -2.70 Mn
Jun 30, 2023 -2.70 Mn
Mar 31, 2023 -565,000.00
Mar 31, 2023 -565,000.00